cdmo.directory
← Compare landing

Oxford Biomedica vs Minaris Advanced Therapies

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryOxford BiomedicaMinaris Advanced Therapies
SummaryGlobal viral vector CDMO with 30 years of expertise in lentivirus, AAV, and adenovirus manufacturing. Provides end-to-end development and GMP-compliant manufacturing services from preclinical through commercial launch for cell and gene therapy programs.Pure-play cell and gene therapy CDMO with over 25 years of GMP manufacturing, process development, and biosafety testing expertise. Serves advanced therapy innovators globally from early stage through commercialization.
Services
  • Upstream Processing
  • Downstream Processing
  • Viral Vector Manufacturing
  • AAV Manufacturing
  • Lentiviral Vector Manufacturing
  • Cell Therapy Manufacturing
  • Vaccine Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Process Development
  • Technology Transfer
  • CMC Analytical Development
  • CMC Regulatory Submission Support
  • Monoclonal Antibody (mAb) Manufacturing
  • Recombinant Protein Manufacturing
  • Cell-Line Development
  • Viral Vector Manufacturing
  • AAV Manufacturing
  • Lentiviral Vector Manufacturing
  • Cell Therapy Manufacturing
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Vaccine Manufacturing
  • Process Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • Stability Testing & Storage
Modalities
  • Cell Therapy
  • Gene Therapy
  • Vaccine
  • AAV / Viral Vector Platform
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • Vaccine
  • AAV / Viral Vector Platform
Development capabilities
  • Analytical method development
  • Analytical method development
  • ICH stability testing
  • Cell line development
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Product (DP)
  • Liquid Vials
  • Max bioreactor: Mid-scale clinical (≤2,000 L)
  • Expression: Mammalian
  • Expression: Cell-Free
  • Expression: Viral Vector
  • Single-Use / Disposable
  • Stainless Steel
  • Drug Substance (DS)
  • Drug Product (DP)
  • Expression: Mammalian
  • Expression: Viral Vector
Locations
  • Facility, UK, United Kingdom
  • Facility, Europe, France
  • Facility, USA, United States
  • Headquarters, Oxford, Oxfordshire, United Kingdom
  • Oxbox Manufacturing, Oxford, Oxfordshire, United Kingdom
  • Harrow House Manufacturing, Oxford, Oxfordshire, United Kingdom
  • Wallingford Manufacturing, Wallingford, Oxfordshire, United Kingdom
  • Yarnton Manufacturing, Oxford, Oxfordshire, United Kingdom
  • Bedford Manufacturing, Bedford, Massachusetts, United States
  • Durham Manufacturing, Durham, North Carolina, United States
  • Lyon Manufacturing, Lyon, Auvergne-Rhône-Alpes, France
  • Strasbourg Manufacturing, Illkirch-Graffenstaden, Grand Est, France
  • EU Support Office, Dublin, Dublin, Ireland
  • Chancery Gate Manufacturing, Oxford, Oxfordshire, United Kingdom
  • Yarnton Manufacturing, Yarnton, Oxfordshire, United Kingdom
  • US Facility, United States, United States
  • European Facility, France, France
  • Headquarters, Philadelphia, PA, United States
  • Philadelphia, Philadelphia, PA, United States
  • Allendale, Allendale, NJ, United States
  • Taufkirchen, Taufkirchen, Bavaria, Germany
  • London, London, England, United Kingdom
  • Yokohama, Yokohama, Kanagawa, Japan
  • Manufacturing & Testing, Philadelphia, PA, United States
  • Manufacturing, Allendale, NJ, United States
  • Manufacturing, Taufkirchen, Bavaria, Germany
  • Office, London, England, United Kingdom
  • Manufacturing, Yokohama, Kanagawa, Japan
  • Manufacturing & Testing, Allendale, NJ, United States
  • Manufacturing & Testing, Taufkirchen, Bavaria, Germany
  • Manufacturing & Testing, Yokohama, Kanagawa, Japan
Certifications
  • FDA · Identifier: Drug Master File (DMF)
  • FDA · Identifier: Commercial manufacturing approval
  • EMA · Identifier: Commercial manufacturing approval
  • PMDA · Identifier: Commercial manufacturing approval
  • FDA · Identifier: FDA approval for commercial manufacturing
  • EMA · Identifier: EMA approval for commercial manufacturing
  • PMDA · Identifier: PMDA approval for commercial manufacturing

Find similar companies

Oxford Biomedica alternatives · Minaris Advanced Therapies alternatives

Markdown mirror: /compare/oxb/wuxi-advanced-therapies.md